Four new clinical trials grants from the CIHR for RI-MUHC researchers
The Government of Canada announced investments in 14 new clinical trials to support Canada’s response to major health threats and bolster the...
McGill, industry, CQDM and Brain Canada collaborate for drug discovery
Novel drug could provide hope to those suffering from neuropathic pain and insomnia
Increasing clinical trial expertise at the RI-MUHC
The RI-MUHC ACT-CTU reports on the realization of its vision for 2024 to build a clinical trials community and strengthen trial capabilities at the RI-MUHC
Annual Clinical Research Day event highlights RI-MUHC services and expertise in clinical trials
The Centre for Innovative Medicine and many other clinical research support teams introduced their skills...
Lucy Gilbert honoured for publication in Gynecologic Oncology
The most cited publication and one of the journal’s most read in 2023
New findings illustrate pathway for screening high-risk individuals for pancreatic cancer
An international collaboration of scientists and healthcare professionals is developing a promising surveillance...
A new hope for men with metastatic prostate cancer
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine
An opportunity to learn, celebrate and connect during Black History Month at the RI-MUHC
An expert panel explored Equity, Diversity and Inclusion in research and healthcare
Building an inclusive clinical trial community
An innovative new unit at the RI-MUHC supports health researchers in launching and conducting impactful clinical trials
National Canadian Consortium of Clinical Trial Training (CANTRAIN) takes off successfully
Eighty-four graduate students from across Canada will share over $2 million in studentship and fellowship...